Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Dr. Gunda Sapna Prakash Rao, founder & CEO of Scure Super Speciality Hospital has received the Prestigious HMTV Nari Puraskar 2023 Business
  • inDrive calls on people to ride for a fair price Business
  • Equence Technologies Pvt Ltd Welcomes Mr. Surender Sharma as Chief Growth Officer Technology
  • Global e-magazine Hello Entrepreneurs celebrates its first anniversary Business
  • Atharv Murli and Atharv Heights, The gracious addition to the skyline of Vile Parle Business
  • Experience Premium Living: 3BHK Flats in Bhopal at Green City Extension by Krishna Homes Business
  • Peng Essentials Products Gain Popularity on TV Shows as Innovative Designs Impress Viewers Business
  • Meet 10 Leaders who make India a Global Bright Spot Health

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • GenWorks Closes Healthcare Gap with Digitisation For Underserved Communities Health
  • International Diabetes Organisations are unanimous on Diabetes remission through diet Health
  • Dr. Balaraju Naidu Revolutionizes Orthopedics with Robotic Surgeries; ONUS Hospital Celebrates 5th Anniversary Health
  • Dr. Sukanya Mehra Champions Cervical Cancer Awareness and Prevention on International Women’s Day Health
  • What Makes a Health Insurance Plan Worth the Premium? Health
  • Riyo Advertising and ALERT-INDIA Releases First Video Campaign to Tackle Leprosy Stigma in India Health

Recent Posts

  • You Don’t Usually Expect a New Lyricist to Get an A.R. Rahman Project,” Says Vishwadeep Zeest
  • JAIN (Deemed-to-be University) Sets New Standards in Occupational Therapy Education with Future-Ready BOT Program
  • JAIN (Deemed-to-be University) Introduces Generative AI Certification for BCA IT for Healthcare Students, Powering the Next Wave of Digital Healthcare Leaders
  • JAIN (Deemed-to-be University) Powers the Next Wave of Disease Defence with the M.Sc Virology and Immunology Program
  • KRAFTON India Introduces Industry-First ‘BGMI Career Mode’ in an Attempt to Offer Real-Life, Career-Relevant Skill Insights via BGMI Gameplay

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Share Your Articles: Empowering Indian Start-ups to Reach a Global Audience Business
  • Strategic Shift to Secure Malaysia’s Palm Oil Industry Business
  • Walnuts demands increase this festive session, Chilean walnuts ruling the market Business
  • Amol Mehra joins Exide as President and Chief Procurement Officer Business
  • Two-Time Amazon Bestseller at 16, Shaurya Singhvi Sets a New Benchmark Lifestyle
  • Neetu Yoshi Limited IPO Opens on June 27, 2025 Business
  • British Wellness Brings A New Era in Affordable Healthcare Health
  • Missed Veganuary? Here’s a second chance with Choose Chicken-Free Week Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme